UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 648

Sortiert nach

PSA and obesity among men with localized prostate cancer: results of the ANDROCAN study

World journal of urology, 2021-08, Vol.39 (8), p.2945-2951

2021

Link zum Volltext

Verfügbarkeit prüfen

Sexual steroids in serum and prostatic tissue of human non‐cancerous prostate (STERPROSER trial)

The Prostate, 2017-11, Vol.77 (15), p.1512-1519

2017

Link zum Volltext

Verfügbarkeit prüfen

Relationship of preoperative androgen levels and metabolic syndrome with quality of life and erectile function in patients who are to undergo radical prostatectomy

Asian journal of andrology, 2021-09, Vol.23 (5), p.520-526

2021

Link zum Volltext

Verfügbarkeit prüfen

Metabolic syndrome, levels of androgens, and changes of erectile dysfunction and quality of life impairment 1 year after radical prostatectomy

Asian journal of andrology, 2021-07, Vol.23 (4), p.370-375

2021

Link zum Volltext

Verfügbarkeit prüfen

Prostate‐specific antigen (PSA) concentrations in hypogonadal men during 6 years of transdermal testosterone treatment

BJU international, 2013-05, Vol.111 (6), p.880-890

2013

Link zum Volltext

Verfügbarkeit prüfen

Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma

Blood, 2007-06, Vol.109 (11), p.4914-4923

2007

Link zum Volltext

Verfügbarkeit prüfen

Cancer/Testis Genes in Multiple Myeloma: Expression Patterns and Prognosis Value Determined by Microarray Analysis

Journal of Immunology, 2007-03, Vol.178 (5), p.3307-3315

2007

Link zum Volltext

Verfügbarkeit prüfen

A rare renal malakoplakia mimicking renal tumor presenting with deep vein thrombosis and bilateral pulmonary embolism in a 58-year-old woman

Urology case reports, 2021-01, Vol.34, p.101431, Article 101431

2021

Link zum Volltext

Verfügbarkeit prüfen

Prostate cancer risk in testosterone-treated men

Journal of steroid biochemistry and molecular biology, 2006-12, Vol.102 (1), p.261-266

Raynaud, Jean-Pierre

2006

Link zum Volltext

Verfügbarkeit prüfen

High incidence of predominant Gleason pattern 4 localized prostate cancer is associated with low serum testosterone

The Journal of urology, 2011-10, Vol.186 (4), p.1400

2011

Link zum Volltext

Verfügbarkeit prüfen

RCL2, a New Fixative, Preserves Morphology and Nucleic Acid Integrity in Paraffin-Embedded Breast Carcinoma and Microdissected Breast Tumor Cells

The Journal of molecular diagnostics : JMD, 2006-05, Vol.8 (2), p.157-169

2006

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the Clinical Benefit of Permixon and Tamsulosin in Severe BPH Patients—PERMAL Study Subset Analysis

European urology, 2004-06, Vol.45 (6), p.773-780

2004

Link zum Volltext

Verfügbarkeit prüfen

Comparison of phytotherapy (Permixon®) with finasteride in the treatment of benign prostate hyperplasia: A randomized international study of 1,098 patients

The Prostate, 1996-10, Vol.29 (4), p.231-240

1996

Link zum Volltext

Verfügbarkeit prüfen

Testosterone deficiency syndrome: Treatment and cancer risk

Journal of steroid biochemistry and molecular biology, 2009-03, Vol.114 (1), p.96-105

Raynaud, Jean-Pierre

2009

Link zum Volltext

Verfügbarkeit prüfen

Aggressiveness of Localized Prostate Cancer: the Key Value of Testosterone Deficiency Evaluated by Both Total and Bioavailable Testosterone: AndroCan Study Results

Discover. Oncology, 2019-02, Vol.10 (1), p.36-44

2019

Link zum Volltext

Verfügbarkeit prüfen

Favorable outcome in a case of Mycoplasma pneumoniae-associated crescentic glomerulonephritis

Pediatric nephrology (Berlin, West), 2010-09, Vol.25 (9), p.1765-1769

2010

Link zum Volltext

Verfügbarkeit prüfen

T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?

Human pathology, 2008-02, Vol.39 (2), p.194-200

2008

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological effects of the lipidosterolic extract of Serenoa repens (Permixon®) on rat prostate hyperplasia induced by hyperprolactinemia: Comparison with finasteride

The Prostate, 2000-04, Vol.43 (1), p.49-58

2000

Link zum Volltext

Verfügbarkeit prüfen

Comparison of a Phytotherapeutic Agent (Permixon) with an α-Blocker (Tamsulosin) in the Treatment of Benign Prostatic Hyperplasia: A 1-Year Randomized International Study

European urology, 2002-05, Vol.41 (5), p.497-507

2002

Link zum Volltext

Verfügbarkeit prüfen

Induction of apoptosis and inhibition of cell proliferation by the lipido-sterolic extract of Serenoa repens (LSESr, Permixon®) in benign prostatic hyperplasia

The Prostate, 2000-11, Vol.45 (3), p.259-266

2000

Link zum Volltext

Verfügbarkeit prüfen

Adhesiveness of a new testosterone-in-adhesive matrix patch after extreme conditions

International journal of pharmaceutics, 2009-06, Vol.375 (1), p.28-32

2009

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of type 1 and type 2 5α-reductase activity by free fatty acids, active ingredients of Permixon

The Journal of steroid biochemistry and molecular biology, 2002-10, Vol.82 (2), p.233-239

2002

Link zum Volltext

Verfügbarkeit prüfen

Serum Bioavailable Testosterone: Assayed or Calculated?

Clinical chemistry (Baltimore, Md.), 2006-03, Vol.52 (3), p.474-481

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 648

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(513)
Mit Volltextzugriff
(590)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(264)
EZB Electronic Journals Library
(247)
Ingenta
(247)
Elsevier ScienceDirect Journals Complete
(176)
Journals@Ovid Complete
(153)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(114)
Single Journals
(101)
Wiley-Blackwell Journals
(82)
IngentaConnect Journals
(77)
Wiley Online Library
(63)
SpringerLink
(33)
Oxford Journals
(30)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(25)
Nature
(19)
Ebook Central Perpetual and DDA
(18)
Oxford Journals 2020 Medicine
(18)
eBooks on EBSCOhost
(16)
JSTOR All Journals
(15)
Nexis
(12)
IEEE Electronic Library Online
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation

PSA and obesity among men with localized prostate cancer: results of the ANDROCAN study

Sexual steroids in serum and prostatic tissue of human non‐cancerous prostate (STERPROSER trial)

Relationship of preoperative androgen levels and metabolic syndrome with quality of life and erectile function in patients who are to undergo radical prostatectomy

Metabolic syndrome, levels of androgens, and changes of erectile dysfunction and quality of life impairment 1 year after radical prostatectomy

Prostate‐specific antigen (PSA) concentrations in hypogonadal men during 6 years of transdermal testosterone treatment

Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma

Cancer/Testis Genes in Multiple Myeloma: Expression Patterns and Prognosis Value Determined by Microarray Analysis

A rare renal malakoplakia mimicking renal tumor presenting with deep vein thrombosis and bilateral pulmonary embolism in a 58-year-old woman

Prostate cancer risk in testosterone-treated men

High incidence of predominant Gleason pattern 4 localized prostate cancer is associated with low serum testosterone

RCL2, a New Fixative, Preserves Morphology and Nucleic Acid Integrity in Paraffin-Embedded Breast Carcinoma and Microdissected Breast Tumor Cells

Evaluation of the Clinical Benefit of Permixon and Tamsulosin in Severe BPH Patients—PERMAL Study Subset Analysis

Comparison of phytotherapy (Permixon®) with finasteride in the treatment of benign prostate hyperplasia: A randomized international study of 1,098 patients

Testosterone deficiency syndrome: Treatment and cancer risk

Aggressiveness of Localized Prostate Cancer: the Key Value of Testosterone Deficiency Evaluated by Both Total and Bioavailable Testosterone: AndroCan Study Results

Favorable outcome in a case of Mycoplasma pneumoniae-associated crescentic glomerulonephritis

T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?

Pharmacological effects of the lipidosterolic extract of Serenoa repens (Permixon®) on rat prostate hyperplasia induced by hyperprolactinemia: Comparison with finasteride

Comparison of a Phytotherapeutic Agent (Permixon) with an α-Blocker (Tamsulosin) in the Treatment of Benign Prostatic Hyperplasia: A 1-Year Randomized International Study

Induction of apoptosis and inhibition of cell proliferation by the lipido-sterolic extract of Serenoa repens (LSESr, Permixon®) in benign prostatic hyperplasia

Adhesiveness of a new testosterone-in-adhesive matrix patch after extreme conditions

Inhibition of type 1 and type 2 5α-reductase activity by free fatty acids, active ingredients of Permixon

Mass spectrometry-based proteomics in clinical practice amyloid typing: state-of-the-art from a French nationwide cohort

Serum Bioavailable Testosterone: Assayed or Calculated?

Suchergebnisse filtern